Fujifilm plots $928M infusion at Danish biologics plant to double production capacity kblankenship Tue, 06/09/2020 – 13:13 More: Fujifilm plots 8M infusion at Danish biologics plant to double production capacity Source: fierce
read moreSanofi’s Sarclisa rejected by NICE over uncertainties on total benefit, cost-effectiveness esagonowsky Tue, 06/09/2020 – 11:02 More: Sanofi's Sarclisa rejected by NICE over uncertainties on total benefit, cost-effectiveness Source: fierce
read moreAstraZeneca ditches plan for Gilead merger amid industry skepticism: report aliu Tue, 06/09/2020 – 09:50 More: AstraZeneca ditches plan for Gilead merger amid industry skepticism: report Source: fierce
read moreAbbVie’s Humira defense may keep prices high, but it’s still legal, judge rules esagonowsky Tue, 06/09/2020 – 09:27 More: AbbVie's Humira defense may keep prices high, but it's still legal, judge rules Source: fierce
read moreWuXi Biologics inks lease agreement for 3rd U.S. facility in global expansion push kblankenship Tue, 06/09/2020 – 09:18 More: WuXi Biologics inks lease agreement for 3rd U.S. facility in global expansion push Source: fierce
read moreThe study failed to meet statistical significance for the primary endpoint, however, it did show a number of other significant benefits More: Soleno's drug misses key goal in Prader-Willi trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals